Autres langues Alar Pharmaceuticals Inc.

Actions

6785

TW0006785009

Cours en clôture Taipei Exchange Autres places de cotation 00:00:00 19/06/2024			Varia. 5j.	Varia. 1 janv.
246,5 ^TWD	-1,60%		-2,95%	+17,66%

10/05	Alar Pharmaceuticals Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
14/03	Alar Pharmaceuticals Inc. publie ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Alar Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05
Alar Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Alar Pharmaceuticals Inc. Has Received Notice of Allowance for Patent in Taiwan	07/03
Alar Pharmaceuticals Inc. Approves Dividend Distribution for the Year Ended December 31, 2023, Payable on June 28, 2024	06/03
Gilva Therapeutics, INC. announced that it expects to receive TWD 30 million in funding from Alar Pharmaceuticals Inc.	05/03
Alar Pharmaceuticals Inc. Receives Notice of Allowance for the Patent Ketamine Pamoate and Use Thereof from United States Patent and Trademark Office	22/02
Alar Pharmaceuticals Inc. Receives Notice of Allowance for the Patent Ketamine Pamoate and Use Thereof from Japan Patent Office	22/02
Alar Pharmaceuticals Inc. Receives Notice of Allowance for the Patent Ketamine Pamoate and Use Thereof from Instituto Mexicano De La Propiedad Industrial	19/02
Alar Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	08/11
Indivior Enters an Exclusive Licensing Agreement with Alar Pharmaceuticals	11/10/23
Alar Pharmaceuticals Inc.(TPEX:6785) added to S&P Global BMI Index	18/09/23
Alar Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23
Alar Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Alar Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	03/03/23
Alar Pharmaceuticals Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	11/08/22
Alar Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	24/03/22
Alar Pharmaceuticals Inc. Announces Significant Progress on Developing Long-acting Buprenorphine Injectable ALA-1000	12/01/22
Alar Pharmaceuticals Inc. Reports Earnings Results for the Half Year Ended June 30, 2021	13/08/21
Alar Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	25/03/21
Alar Presents Positive Interim Results of Long-Acting Buprenorphine Injectable in Opioid Dependent Patients	09/03/21

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Alar Pharmaceuticals Inc.

Actions

6785

TW0006785009

Autres langues

Filtres